Dr. Shane Abdunnur, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9990 Double R Blvd Ste 200, Reno, NV 89521 Phone: 775-348-8800 Fax: 775-348-8818 |
James Joseph Lynch, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 9990 Double R Blvd, Suite 200, Reno, NV 89521 Phone: 775-348-8800 Fax: 775-348-8818 |
Marshall E Tolbert, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5590 Kietzke Ln, Reno, NV 89511 Phone: 775-323-2080 Fax: 775-323-8216 |
News Archive
Patients who had a diagnosis of Parkinson's disease (PD) with dementia (PDD) or dementia with Lewy bodies (DLB) and had higher levels of Alzheimer's disease (AD) pathology in their donated post-mortem brains also had more severe symptoms of these Lewy body diseases (LBD) during their lives, compared to those whose brains had less AD pathology, according to research from the Perelman School of Medicine at the University of Pennsylvania.
Researchers at the National Institute of Physiological Science have revealed that mutual eye contact synchronizes spontaneous activity in specific areas of the brains of two interacting parties. The finding indicates that this synchronized brain activity is crucial in establishing and facilitating face-to-face social interaction.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that generic erosion of premium-priced branded agents will offset sales of new agents and will cause the acute coronary syndrome market for drugs in the hospital setting to decrease from $800 million in 2008 to $729 million in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
NXT Nutritionals Holdings, Inc., developer and marketer of SUSTA™ Natural Sweetener, the great tasting, all-natural, healthier sweetener, announced today that the Company has secured $2.35 million in financing through a private placement offering (the "Offering"). Proceeds from the Offering will be used for general corporate purposes and to fund further development and marketing of its SUSTA™ products.
› Verified 2 days ago